These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 26759000

  • 21. Single vs split dose of prednisolone in the treatment of relapses of childhood nephrotic syndrome.
    Weerasooriya WALK, Abeyagunawardena AS, Thalgahagoda RS.
    Eur J Pediatr; 2023 Apr; 182(4):1741-1747. PubMed ID: 36757496
    [Abstract] [Full Text] [Related]

  • 22. A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment.
    Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K, Japanese Study Group of Kidney Disease in Children.
    Kidney Int; 2015 Jan; 87(1):225-32. PubMed ID: 25054775
    [Abstract] [Full Text] [Related]

  • 23. The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome.
    Abeyagunawardena AS, Dillon MJ, Rees L, van't Hoff W, Trompeter RS.
    Pediatr Nephrol; 2003 Sep; 18(9):919-24. PubMed ID: 12883981
    [Abstract] [Full Text] [Related]

  • 24. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
    Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS.
    Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
    [Abstract] [Full Text] [Related]

  • 25. Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome.
    Nakanishi K, Iijima K, Ishikura K, Hataya H, Nakazato H, Sasaki S, Honda M, Yoshikawa N, Japanese Study Group of Renal Disease in Children.
    Clin J Am Soc Nephrol; 2013 May; 8(5):756-62. PubMed ID: 23371961
    [Abstract] [Full Text] [Related]

  • 26. Frequency of relapse among Nigerian children with steroid-sensitive nephrotic syndrome.
    Esezobor CI, Ladapo TA, Lesi FE.
    Niger J Clin Pract; 2016 May; 19(2):254-8. PubMed ID: 26856291
    [Abstract] [Full Text] [Related]

  • 27. Comparative study of prednisolone alone and prednisolone plus fusidic acid in the treatment of children with steroid-responsive nephrotic syndrome.
    Cerkauskiene R, Kaltenis P.
    Medicina (Kaunas); 2005 May; 41 Suppl 1():26-30. PubMed ID: 15901972
    [Abstract] [Full Text] [Related]

  • 28. Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial.
    Sheikh S, Mishra K, Kumar M.
    Pediatr Nephrol; 2021 Oct; 36(10):3143-3150. PubMed ID: 33861375
    [Abstract] [Full Text] [Related]

  • 29. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P.
    Nephrol Dial Transplant; 1993 Oct; 8(12):1326-32. PubMed ID: 8159300
    [Abstract] [Full Text] [Related]

  • 30. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
    Raja K, Parikh A, Webb H, Hothi D.
    Pediatr Nephrol; 2017 Jan; 32(1):99-105. PubMed ID: 27677978
    [Abstract] [Full Text] [Related]

  • 31. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
    Abeyagunawardena AS, Hindmarsh P, Trompeter RS.
    Arch Dis Child; 2007 Jul; 92(7):585-8. PubMed ID: 17284479
    [Abstract] [Full Text] [Related]

  • 32. Long versus standard initial prednisolone therapy in children with idiopathic nephrotic syndrome.
    Paul SK, Muinuddin G, Jahan S, Begum A, Rahman MH, Hossain MM.
    Mymensingh Med J; 2014 Apr; 23(2):261-7. PubMed ID: 24858152
    [Abstract] [Full Text] [Related]

  • 33. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
    Ekka BK, Bagga A, Srivastava RN.
    Pediatr Nephrol; 1997 Oct; 11(5):597-9. PubMed ID: 9323286
    [Abstract] [Full Text] [Related]

  • 34. REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study- protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study.
    Schijvens AM, Dorresteijn EM, Roeleveld N, Ter Heine R, van Wijk JAE, Bouts AHM, Keijzer-Veen MG, van de Kar NCAJ, van den Heuvel LPWJ, Schreuder MF.
    BMJ Open; 2017 Sep 27; 7(9):e018148. PubMed ID: 28963315
    [Abstract] [Full Text] [Related]

  • 35. Equations to estimate prednisone dose using body weight.
    Emma F, Montini G, Gargiulo A.
    Pediatr Nephrol; 2019 Apr 27; 34(4):685-688. PubMed ID: 30368613
    [Abstract] [Full Text] [Related]

  • 36. Single- versus Divided-Dose Prednisolone for the First Episode of Nephrotic Syndrome in Children: An Open-Label RCT.
    Khan T, Akhtar S, Mukherjee D, Basu S, Tse Y, Sinha R.
    Clin J Am Soc Nephrol; 2023 Oct 01; 18(10):1294-1299. PubMed ID: 37335578
    [Abstract] [Full Text] [Related]

  • 37. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
    Bagga A, Hari P, Srivastava RN.
    Pediatr Nephrol; 1999 Nov 01; 13(9):824-7. PubMed ID: 10603129
    [Abstract] [Full Text] [Related]

  • 38. Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial.
    Iijima K, Sako M, Oba MS, Ito S, Hataya H, Tanaka R, Ohwada Y, Kamei K, Ishikura K, Yata N, Nozu K, Honda M, Nakamura H, Nagata M, Ohashi Y, Nakanishi K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children.
    Clin J Am Soc Nephrol; 2014 Feb 01; 9(2):271-8. PubMed ID: 24262503
    [Abstract] [Full Text] [Related]

  • 39. Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook.
    Vester U, Kranz B, Zimmermann S, Hoyer PF.
    Pediatr Nephrol; 2003 Jul 01; 18(7):661-4. PubMed ID: 12750975
    [Abstract] [Full Text] [Related]

  • 40. Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference?
    Saadeh SA, Baracco R, Jain A, Kapur G, Mattoo TK, Valentini RP.
    Pediatr Nephrol; 2011 Dec 01; 26(12):2167-71. PubMed ID: 21769641
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.